HDFC Pharma and Healthcare Fund - Direct Plan - Growth Option

HDFC Mutual Fund · Sectoral/Thematic · Direct · Growth

NAV · as of 11/09/2026

22.71

-0.44%

+27.47%

Key stats

Expense ratio: 1.11%
AUM: ₹2.94 K Cr
Launched: 04/10/2023
Fund manager: Dhruv Muchhal; Nikhil Mathur
Portfolio turnover: 0.37%
Risk: Very High Risk
Min lump-sum: ₹100
Min SIP: ₹100/mo
Fresh lump-sum: Accepted
Fresh SIP: Accepted

NAV history

HDFC Pharma and Healthcare Fund - Direct Plan - Growth Option

13/08/2026 to 11/09/2026

O - H - L -

1W+1.37%

1M+2.41%

3M+11.82%

6M+29.08%

1Y+27.47%

MAX+127.94%

Top holdings

38 disclosed

1.
Sun Pharmaceuticals Industries Ltd
Healthcare
9.96%
2.
Divi's Laboratories Ltd
Healthcare
7.16%
3.
Max Healthcare Institute Ltd Ordinary Shares
Healthcare
5.57%
4.
Lupin Ltd
Healthcare
5.26%
5.
Cipla Ltd
Healthcare
5.19%
6.
Aster DM Quality Care Ltd Ordinary Shares
Healthcare
5.05%
7.
Acutaas Chemicals Ltd
Basic Materials
4.58%
8.
Alkem Laboratories Ltd
Healthcare
4.00%
9.
Anthem Biosciences Ltd
Healthcare
3.81%
10.
Ipca Laboratories Ltd
Healthcare
3.53%
11.
Treps - Tri-Party Repo
3.32%
12.
Fortis Healthcare Ltd
Healthcare
3.18%
13.
Global Health Ltd
Healthcare
3.08%
14.
Krishna Institute of Medical Sciences Ltd
Healthcare
3.07%
15.
Neuland Laboratories Ltd
Healthcare
2.93%
16.
Glenmark Pharmaceuticals Ltd
Healthcare
2.88%
17.
Vijaya Diagnostic Centre Ltd
Healthcare
2.53%
18.
Shilpa Medicare Ltd
Healthcare
2.48%
19.
Zydus Lifesciences Ltd
Healthcare
2.34%
20.
Metropolis Healthcare Ltd
Healthcare
2.24%
21.
Wockhardt Ltd
Healthcare
2.11%
22.
Sai Life Sciences Ltd
Healthcare
1.71%
23.
Rubicon Research Ltd
Healthcare
1.70%
24.
Thyrocare Technologies Ltd
Healthcare
1.51%
25.
Eris Lifesciences Ltd Registered Shs
Healthcare
1.49%
26.
Ajanta Pharma Ltd
Healthcare
1.42%
27.
Corona Remedies Ltd
Healthcare
1.31%
28.
Gland Pharma Ltd
Healthcare
1.20%
29.
Jubilant Pharmova Ltd
Healthcare
1.18%
30.
Biocon Ltd
Healthcare
1.17%
31.
Dr Reddy's Laboratories Ltd
Healthcare
1.04%
32.
Bajaj Healthcare Ltd
Healthcare
0.77%
33.
Laxmi Dental Ltd
Healthcare
0.56%
34.
Net Current Assets
0.54%
35.
Novartis India Ltd
Healthcare
0.53%
36.
Cohance Lifesciences Ltd
Healthcare
0.44%
37.
Jupiter Life Line Hospitals Ltd
Healthcare
0.27%
38.
Laurus Labs Ltd
-

Sector allocation

Healthcare92.65%
Basic Materials4.58%
Unclassified3.86%

Comparable peers

HDFC Pharma & Healthcare Growth Direct Plan
HDFC Pharma & Healthcare (G) · ₹2.94 K Cr AUM
1Y+28.30%
3Y0.00%
-
SBI Healthcare Opportunities Growth Direct Plan
SBI Healthcare Opportunities (G) · ₹5.80 K Cr AUM
1Y+22.13%
3Y+24.61%
-
Mirae Asset Healthcare Growth Direct Plan
Mirae Healthcare (G) · ₹3.44 K Cr AUM
1Y+20.35%
3Y+23.20%
-
UTI Healthcare Growth Direct Plan
UTI Healthcare (G) · ₹1.44 K Cr AUM
1Y+17.28%
3Y+24.42%
-
HDFC Transportation & Logistics Growth Direct Plan
HDFC Transportation & Logistics (G) · ₹1.96 K Cr AUM
1Y+9.79%
3Y+25.46%
-

Investment objective

To provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies. There is no assurance that the investment objective of the Scheme will be realized.

Scheme details

Scheme code: 152082
Fund house: HDFC Mutual Fund
Category: Open Ended
Type: Equity Scheme
Sub-category: Sectoral/Thematic
Plan: Direct
Return type: Growth
ISIN (Growth): INF179KC1HO1
ISIN (Div. Reinvest): -
Tradable on exchange: No

Kuvera page